Many individuals using the medication Mounjaro are encountering a weight loss plateau where their progress suddenly halts. To overcome this, some users are adoping a mix of nutritional adjustments and unconventional dosing methods to restart their weight loss journey.

The £300-a-month struggle with GLP-1 plateaus

For many patients, the frustration of a weight loss stall is compounded by the significant financial investment required for the medication. According to the report, some users pay between £180 and £300 per month for Mounjaro,making the experience of a plateau feel particularly infuriating when the desired goal remains out of reach.

This phenomenon is part of a broader trend where the initial "magic" of GLP-1 drugs—characterized by intense appetite suppression and slower gastric emptying—begins to fade. As the body adapts to the medication, old eating habits often resurface, leading to a stabilization of weight that can feel like a failure to the user.

Rob Hobson's 1.6g protein target for metabolism

To combat metabolic slowdown, some users are shifting their focus toward aggressive protein intake. Rob Hobson, a consultant nutritionist at Healthspan and author of The Low Appetite Cookbook, recommends that individuals aim for 1.2g to 1.6g of protein per kilogram of their target body wieght every day.

As reported, this strategy involves consuming 25-30g of protein from sources like fish, eggs, tofu , or meat at every meal. By prioritizing protein before carbohydrates and vegetables, users aim to support muscle mass and increase energy, which helps the body burn more calories even during periods of rest.

Why stomach injections beat the 'TikTok' arm method

There is a growing trend on TikTok suggesting that switching injection sites—such as moving from the stomach to the upper arm or thigh—can accelerate weight loss. however, the biological reality of drug absorption suggests that the stomach remains the most reliable site for Mounjaro.

The medication is designed to be injected into fatty tissue to slow absorption, allowing the GLP-1 to bind to blood proteins and remain active for several days. If a user has already lost significant weight, injecting into the arm or thigh may accidentally hit muscle tissue, which can lead to faster, less predictable absorption and a shorter duration of effectiveness.

The '60-click' gamble of off-label dosing

Some users have turned to a practice known as "click-counting" to fine-tune their dosage without increasing their spending. This involves using a higher-dose pen—such as moving from 2.5mg to 5mg—but only dialing the pen to a specific number of clicks to achieve a custom dose, such as 3mg or 4mg.

The report notes that a full dose typically equals 60 clicks, meaning 30 clicks would represent a half-dose. While this allows users to stretch the cost of a pen over six or seven weeks, the report explicitly states that this move is considered "off label" and is not recommended by pharmacists.

The missing medical consensus on 'click-counting' risks

While the report highlights that pharmacists discourage click-counting, it leaves several critical safety questions unanswered.. Specifically, there is no detailed medical explanation provided regarding the long-term risks of inconsistent dosing or the potential for medication instability when a pen is not used as directed by the manufacturer.

Furthermore, the source primarily relies on user experiences from Facebook support groups and TikTok, leaving a gap in verified clinical data. It remains unclear whether these "hacks" provide a sustainable metabolic boost or if they simply create a temporary psychological sense of control over a complex biological process.